Attendees
Speakers
Future of Personalized Medicine Summit for Oncology is a 2-day networking event with revolutionary keynotes, case studies, and panels. It brings together experts from the fields of Pharmaceutical, Biotechnology, Hospitals, and Academics to discuss how AI and Blockchain technologies are impacting the Future of Medicine. A one of a kind forum to benchmark, gain subject matter expertise & business intelligence by collaborating with industry leaders from the field of Engineering, Diagnostics, Bioinformatics, Drug Discovery, Therapies and more!
As cancer is a genetic disease driven by heritable or somatic mutations, new DNA sequencing technologies will have a significant impact on the detection, management, and treatment of disease. With targeted therapies becoming the new standard of care in oncology, NGS-driven companion diagnostics are widely seen as driving the selection of treatments to optimize patient outcomes in the future. From a clinical perspective, there is great potential for NGS in the management and treatment of human health.
The discussion around big data’s role in personalized medicine has been buzzing for several years now. However, it’s promise has yet to come to fruition as healthcare entities and providers struggle to leverage big data for personalized care.
In healthcare, we are dealing with data from multiple sources like Clinical Data, Omics Data, Claims Data and User Generated Data. Integrating this data with new technologies into “smart data” is no easy task, but it
is increasingly possible.
Personalized Medicine promises to increase the quality of clinical care and, in some cases, to decrease health care costs.
The biggest hurdles are economic, not scientific. Over the next few decades, the development
of “omics” sciences (such as genomics) and supporting technologies will enable the creation of more and more personalized-medicine tests. Yet poorly aligned incentives for stakeholders could hamper their use.
“ As a result of biomedical advances, we are facing the possibility of a future in which our humanity itself will be altered beyond recognition.” - Francis Fukuyama
Innovative keynotes delivered by the industry's true heavyweights, covering practical challenges and subjects which are exclusively entailed in our agenda. Gain subject matter expertise, network, and collaborate to explore solutions that shed light on future business models impacting revenue inflows.
Futurista Start-up Elevate is a dedicated platform for Startups and VCs. We offer industry-specific startups a showcasing opportunity, enabling them to connect with corresponding VCs and Mentors. A win-win dynamic is created to attain the desired exposure for startups who are looking forward to scaling up their businesses.
A smart application will help you connect with key decision makers, share files, brainstorm ideas, and have a seamless networking experience. A comprehensive module covering the entire event, compiled for training purposes, to be made available post-conference, exclusively for the attendees.
Evidence Based Medicine
Precision Oncology
Digital phenotyping
Genome targeted drugs
Computational genomics
Biochips
Digital Biomarker
Nutrigenomics
Value based pricing
Next Gen Sequencing
Microbiomics
DNA Database
CRISPR Cas9
Proteomics
Personalized Medical Devices
Biobanking
Companion Diagnostics
Nanomedicine
Electronic Health Record
Organ on chip
Telemedicine
DNA Profiling
Predictive Medicine
Preventive Medicine
Personalised Cancer Vaccine
Liquid Biopsy
Early Cancer Detection
mHealth
Digital Pathology
In Vitro Diagnostics
Futurista Startup Elevate is a platform that transforms big-ideas into reality! The FOPM 2019 will fuel start-ups to take themselves to the top by providing access to VC's, Mentors, and Potential Clientele from the corresponding industries. The perks include Product Showcasing, Speaking Slots, and Campaigns running among our thoroughly researched pack of delegates.
Learn More